These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular pathology of gastrointestinal stromal tumors and implications for treatment and prognosis. Parkin B; Chugh R Curr Probl Cancer; 2011; 35(5):245-54. PubMed ID: 22118564 [No Abstract] [Full Text] [Related]
3. Gastrointestinal Stromal Tumors: The GIST of Precision Medicine. Mei L; Smith SC; Faber AC; Trent J; Grossman SR; Stratakis CA; Boikos SA Trends Cancer; 2018 Jan; 4(1):74-91. PubMed ID: 29413424 [TBL] [Abstract][Full Text] [Related]
4. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors. Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events. Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677 [TBL] [Abstract][Full Text] [Related]
6. Current research and treatment for gastrointestinal stromal tumors. Lim KT; Tan KY World J Gastroenterol; 2017 Jul; 23(27):4856-4866. PubMed ID: 28785140 [TBL] [Abstract][Full Text] [Related]
7. [The importance of mutational status in prognosis and therapy of GIST]. Comandone A; Boglione A Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775 [TBL] [Abstract][Full Text] [Related]
8. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors. Rossi S; Sbaraglia M; Dell'Orto MC; Gasparotto D; Cacciatore M; Boscato E; Carraro V; Toffolatti L; Gallina G; Niero M; Pilozzi E; Mandolesi A; Sessa F; Sonzogni A; Mancini C; Mazzoleni G; Romeo S; Maestro R; Dei Tos AP Oncotarget; 2016 May; 7(21):30109-18. PubMed ID: 27097112 [TBL] [Abstract][Full Text] [Related]
9. KIT mutations and sequence changes in genes encoding SDH complex possibly need not be mutually exclusive in gastrointestinal stromal tumors. Daum O; Sedivcova M; Dubova M; Michal M Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):523-4. PubMed ID: 22495360 [No Abstract] [Full Text] [Related]
10. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036 [TBL] [Abstract][Full Text] [Related]
11. Genetics of Gastrointestinal Stromal Tumors: A Heterogeneous Family of Tumors? Patil DT; Rubin BP Surg Pathol Clin; 2015 Sep; 8(3):515-24. PubMed ID: 26297068 [TBL] [Abstract][Full Text] [Related]
12. [Application and value of mutation detection in diagnosis and treatment of gastrointestinal stromal tumor]. Cao H; Wang M Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):208-11. PubMed ID: 23536336 [TBL] [Abstract][Full Text] [Related]
13. [Gastrointestinal stromal tumor molecular diagnostics in relation to the prediction of a therapeutic response to targeted biological therapy]. Augustináková A; Kodet R Cesk Patol; 2011 Oct; 47(4):148-52. PubMed ID: 22145212 [TBL] [Abstract][Full Text] [Related]
14. Classification of gastrointestinal stromal tumor syndromes. Gopie P; Mei L; Faber AC; Grossman SR; Smith SC; Boikos SA Endocr Relat Cancer; 2018 Feb; 25(2):R49-R58. PubMed ID: 29170162 [TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal Stromal Tumors with KIT Mutation Coexisting with Wild-type Gastrointestinal Stromal Tumors in a Patient with Neurofibromatosis Type 1. Li Y; Gao ZD; Yang XD; Ye YJ; Wang S; Jiang KW Chin Med J (Engl); 2018 Sep; 131(18):2244-2245. PubMed ID: 30203805 [No Abstract] [Full Text] [Related]
16. Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal Tumor. Gasparotto D; Rossi S; Campagna D; Scavina P; Tiziano FD; Marzotto A; Toffolatti L; Vitelli CE; Amini M; Dei Tos AP; Maestro R J Clin Oncol; 2016 Apr; 34(11):e99-e103. PubMed ID: 25547508 [No Abstract] [Full Text] [Related]
17. Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy. Huss S; Elges S; Trautmann M; Sperveslage J; Hartmann W; Wardelmann E Expert Rev Anticancer Ther; 2015 Jun; 15(6):623-8. PubMed ID: 25831232 [TBL] [Abstract][Full Text] [Related]
18. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs. Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767 [TBL] [Abstract][Full Text] [Related]
19. An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST). Nannini M; Biasco G; Astolfi A; Pantaleo MA J Med Genet; 2013 Oct; 50(10):653-61. PubMed ID: 23833252 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathology and molecular diagnostics of gastrointestinal stromal tumors. Lucas DR Curr Probl Cancer; 2011; 35(5):233-44. PubMed ID: 22118563 [No Abstract] [Full Text] [Related] [Next] [New Search]